Shots:
- Dr. Emanuela Offidani explains how ADHD is increasingly recognized as a lifelong condition affecting both children and adults. She highlights that symptoms can differ across genders and are often underdiagnosed in women due to less visible hyperactivity and more internalized symptoms such as inattention and emotional dysregulation.
- The conversation explores how Tris Pharma is advancing ADHD treatment through its proprietary LiquiXR drug delivery technology, designed to provide smoother and sustained medication release throughout the day. The company is also expanding its pipeline with new therapies while exploring digital health tools to improve diagnosis and patient outcomes.
- The discussion highlights the growing role of artificial intelligence, wearables, and digital diagnostics in improving ADHD detection, monitoring, and personalized treatment. Dr. Offidani notes that integrating technology with clinical expertise could significantly enhance diagnosis accuracy and long-term management for patients.
About Emanuela Offidani
Dr. Emanuela Offidani (Ema) is the Medical Director of Digital Health Strategy at Tris Pharma, bringing more than a decade of experience spanning clinical research, clinical development, and medical affairs. Trained as a clinical psychologist, she has established herself as a strategic leader in digital health, working at the forefront of digital therapeutics and Software as a Medical Device (SaMD) to advance innovative approaches in mental health care and patient outcomes.
Ema has played a key role in developing evidence-based digital solutions, strengthening medical affairs frameworks, and collaborating with key opinion leaders to support clinical adoption of emerging technologies. Her work is firmly rooted in scientific rigor, reflected in more than 30 peer-reviewed publications and extensive involvement in research partnerships and evidence generation. Through her leadership, she continues to contribute to shaping the future of digital therapeutics and evidence-driven innovation in healthcare.
Related Post: PharmaShots CXO Talks | A Conversation with Liz Benditt, Founder & CEO, The Balm Box
